Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203924

« Back to Dashboard
NDA 203924 describes PRIMAQUINE PHOSPHATE, which is a drug marketed by Alvogen Inc, Ingenus Pharms Nj, and Bayshore Pharms Llc, and is included in three NDAs. It is available from six suppliers. Additional details are available on the PRIMAQUINE PHOSPHATE profile page.

The generic ingredient in PRIMAQUINE PHOSPHATE is primaquine phosphate. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the primaquine phosphate profile page.

Summary for NDA: 203924

Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 203924

Suppliers and Packaging for NDA: 203924

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
primaquine phosphate
TABLET;ORAL 203924 ANDA Alvogen, Inc. 47781-331 47781-331-10 1000 TABLET, FILM COATED in 1 BOTTLE (47781-331-10)
primaquine phosphate
TABLET;ORAL 203924 ANDA Alvogen, Inc. 47781-331 47781-331-14 14 TABLET, FILM COATED in 1 BOTTLE (47781-331-14)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 15MG BASE
Approval Date:Feb 3, 2014TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus